RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 12 analysts with an average price target of $262.4. This is a potential upside of $13.52 (5.43%) from yesterday's end of day stock price of $248.88.

ResMed's activity chart (see below) currently has 91 price targets and 106 ratings on display. The stock rating distribution of RMD is 73.91% BUY and 26.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.37% with an average time for these price targets to be met of 109.31 days.

Highest price target for RMD is $270, Lowest price target is $164, average price target is $262.4.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 25-Oct-2024.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 34 are a BUY (73.91%), 12 are a HOLD (26.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 months 29 days ago
(25-Oct-2024)

11/11 (100%)

$-8.75 (-3.58%)

211

Buy

$270

$30.22 (12.60%)

$220

3 months 28 days ago
(26-Sep-2024)

7/9 (77.78%)

$27.44 (11.31%)

154

Hold

$200

6 months 29 days ago
(25-Jun-2024)

7/12 (58.33%)

$-17.58 (-8.08%)

84

Buy

$215

$-24.78 (-10.33%)

$215

9 months 27 days ago
(27-Mar-2024)

10/11 (90.91%)

$19.11 (9.76%)

114

$164

$-75.78 (-31.60%)

$158

11 months 29 days ago
(25-Jan-2024)

5/6 (83.33%)

$-21.47 (-11.58%)

162

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 109.31 days on average for the stock forecasts to be realized with a an average price target met ratio 62.37

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

LYANNE HARRISON

Which analyst has the most public recommendations on RMD (ResMed)?

Lyanne Harrison works at BAML and has 17 price targets and 9 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Mike Polark with highest potential upside - $50.08

Which analyst is the currently most reserved on RMD (ResMed)?

Joanne Wuensch with lowest potential downside - -$119.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?